Loading…

Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice

Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cyt...

Full description

Saved in:
Bibliographic Details
Published in:Yàowu shi͡p︡in fenxi 2015-09, Vol.23 (3), p.516-528
Main Authors: Ueng, Yune-Fang, Chen, Chien-Chih, Huang, Yu-Ling, Lee, I-Jung, Yun, Chul-Ho, Chen, Yu-Hsuan, Huang, Chiung-Chiao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863
cites cdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863
container_end_page 528
container_issue 3
container_start_page 516
container_title Yàowu shi͡p︡in fenxi
container_volume 23
creator Ueng, Yune-Fang
Chen, Chien-Chih
Huang, Yu-Ling
Lee, I-Jung
Yun, Chul-Ho
Chen, Yu-Hsuan
Huang, Chiung-Chiao
description Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.
doi_str_mv 10.1016/j.jfda.2015.03.005
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9351787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1021949815000502</els_id><sourcerecordid>2049904915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</originalsourceid><addsrcrecordid>eNp9kttqGzEQhpfS0rhpX6AXRdAbG7KupF3tAUoh5NAUQmtKcy1kadaWWUuOtDLxM_clMo5T0970Qghm_vlmmPmz7D2jU0ZZ9Wk1XXVGTTllYkqLKaXiRTbinJd5VbHyZTZilLO8LdvmJHsT44rSShQtf52d8KZlrGZslP2-6jrQQyS-I-o-gU-RwMMQlB72oZ9pUGQR1BZ8Dy4S5QyxqLZuEcBYcPtKR_Ru8HoZ_BrIrBT0jKRgjXVAjN0sfdws1QBkfHc5m-SLPukUvPNx12MbFzsIKsLZExqZSYMhzmo_WKfW1gBRBtyB5ZLuARMYHB-5EzL-fn45nk1uJvl9ss6j1D9Y459gA7JxWrK2Gt5mrzrVR3j3_J9md9dXvy5u8tsfX79dnN_muqwakXe1YXMDNZ0rzRRo1c3nQjNKDWegBNS8Za1qaqhMU5TU1IUqCtZpURWl0E1VnGZfDtxNmq_BaNxSUL3cBLtWYSe9svLfjLNLufBb2RaC1U2NgI_PgODxJnGQK5-Cw5klp2Xb4mMCVfyg0sHHGKA7dmBU7g0iV3JvELk3iKSFRINg0Ye_ZzuW_HEECj4fBIAb2loIMmq8M17FBjSKNN7-j_8I34XS2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2049904915</pqid></control><display><type>article</type><title>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Ueng, Yune-Fang ; Chen, Chien-Chih ; Huang, Yu-Ling ; Lee, I-Jung ; Yun, Chul-Ho ; Chen, Yu-Hsuan ; Huang, Chiung-Chiao</creator><creatorcontrib>Ueng, Yune-Fang ; Chen, Chien-Chih ; Huang, Yu-Ling ; Lee, I-Jung ; Yun, Chul-Ho ; Chen, Yu-Hsuan ; Huang, Chiung-Chiao</creatorcontrib><description>Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.</description><identifier>ISSN: 1021-9498</identifier><identifier>EISSN: 2224-6614</identifier><identifier>DOI: 10.1016/j.jfda.2015.03.005</identifier><identifier>PMID: 28911711</identifier><language>eng</language><publisher>China (Republic : 1949- ): Elsevier B.V</publisher><subject>Chromatography ; CYP1A protein ; Cytochrome ; Cytochrome P450 ; Drug dosages ; Enzymes ; Females ; Furanocoumarins ; Ingredients ; Males ; Metabolism ; Mice ; Motility ; NAD(P)H:quinone oxidoreductase ; Nicotinamide ; Nicotinamide adenine dinucleotide ; Oral administration ; Original ; Phosphates ; Physiology ; Polyclonal antibodies ; Proteins ; Quinone oxidoreductase ; Rodents ; Ruta graveolens ; Rutin ; Sperm ; Therapeutic applications ; UDP-glucuronosyltransferase ; Uridine</subject><ispartof>Yàowu shi͡p︡in fenxi, 2015-09, Vol.23 (3), p.516-528</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier B.V.</rights><rights>Copyright Elsevier Limited Sep 2015</rights><rights>2015 Taiwan Food and Drug Administration 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</citedby><cites>FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</cites><orcidid>0000-0002-6046-8356</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351787/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1021949815000502$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28911711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ueng, Yune-Fang</creatorcontrib><creatorcontrib>Chen, Chien-Chih</creatorcontrib><creatorcontrib>Huang, Yu-Ling</creatorcontrib><creatorcontrib>Lee, I-Jung</creatorcontrib><creatorcontrib>Yun, Chul-Ho</creatorcontrib><creatorcontrib>Chen, Yu-Hsuan</creatorcontrib><creatorcontrib>Huang, Chiung-Chiao</creatorcontrib><title>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</title><title>Yàowu shi͡p︡in fenxi</title><addtitle>J Food Drug Anal</addtitle><description>Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.</description><subject>Chromatography</subject><subject>CYP1A protein</subject><subject>Cytochrome</subject><subject>Cytochrome P450</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Females</subject><subject>Furanocoumarins</subject><subject>Ingredients</subject><subject>Males</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Motility</subject><subject>NAD(P)H:quinone oxidoreductase</subject><subject>Nicotinamide</subject><subject>Nicotinamide adenine dinucleotide</subject><subject>Oral administration</subject><subject>Original</subject><subject>Phosphates</subject><subject>Physiology</subject><subject>Polyclonal antibodies</subject><subject>Proteins</subject><subject>Quinone oxidoreductase</subject><subject>Rodents</subject><subject>Ruta graveolens</subject><subject>Rutin</subject><subject>Sperm</subject><subject>Therapeutic applications</subject><subject>UDP-glucuronosyltransferase</subject><subject>Uridine</subject><issn>1021-9498</issn><issn>2224-6614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kttqGzEQhpfS0rhpX6AXRdAbG7KupF3tAUoh5NAUQmtKcy1kadaWWUuOtDLxM_clMo5T0970Qghm_vlmmPmz7D2jU0ZZ9Wk1XXVGTTllYkqLKaXiRTbinJd5VbHyZTZilLO8LdvmJHsT44rSShQtf52d8KZlrGZslP2-6jrQQyS-I-o-gU-RwMMQlB72oZ9pUGQR1BZ8Dy4S5QyxqLZuEcBYcPtKR_Ru8HoZ_BrIrBT0jKRgjXVAjN0sfdws1QBkfHc5m-SLPukUvPNx12MbFzsIKsLZExqZSYMhzmo_WKfW1gBRBtyB5ZLuARMYHB-5EzL-fn45nk1uJvl9ss6j1D9Y459gA7JxWrK2Gt5mrzrVR3j3_J9md9dXvy5u8tsfX79dnN_muqwakXe1YXMDNZ0rzRRo1c3nQjNKDWegBNS8Za1qaqhMU5TU1IUqCtZpURWl0E1VnGZfDtxNmq_BaNxSUL3cBLtWYSe9svLfjLNLufBb2RaC1U2NgI_PgODxJnGQK5-Cw5klp2Xb4mMCVfyg0sHHGKA7dmBU7g0iV3JvELk3iKSFRINg0Ye_ZzuW_HEECj4fBIAb2loIMmq8M17FBjSKNN7-j_8I34XS2A</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Ueng, Yune-Fang</creator><creator>Chen, Chien-Chih</creator><creator>Huang, Yu-Ling</creator><creator>Lee, I-Jung</creator><creator>Yun, Chul-Ho</creator><creator>Chen, Yu-Hsuan</creator><creator>Huang, Chiung-Chiao</creator><general>Elsevier B.V</general><general>Food and Drug Administration</general><general>Taiwan Food and Drug Administration</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6046-8356</orcidid></search><sort><creationdate>20150901</creationdate><title>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</title><author>Ueng, Yune-Fang ; Chen, Chien-Chih ; Huang, Yu-Ling ; Lee, I-Jung ; Yun, Chul-Ho ; Chen, Yu-Hsuan ; Huang, Chiung-Chiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Chromatography</topic><topic>CYP1A protein</topic><topic>Cytochrome</topic><topic>Cytochrome P450</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Females</topic><topic>Furanocoumarins</topic><topic>Ingredients</topic><topic>Males</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Motility</topic><topic>NAD(P)H:quinone oxidoreductase</topic><topic>Nicotinamide</topic><topic>Nicotinamide adenine dinucleotide</topic><topic>Oral administration</topic><topic>Original</topic><topic>Phosphates</topic><topic>Physiology</topic><topic>Polyclonal antibodies</topic><topic>Proteins</topic><topic>Quinone oxidoreductase</topic><topic>Rodents</topic><topic>Ruta graveolens</topic><topic>Rutin</topic><topic>Sperm</topic><topic>Therapeutic applications</topic><topic>UDP-glucuronosyltransferase</topic><topic>Uridine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ueng, Yune-Fang</creatorcontrib><creatorcontrib>Chen, Chien-Chih</creatorcontrib><creatorcontrib>Huang, Yu-Ling</creatorcontrib><creatorcontrib>Lee, I-Jung</creatorcontrib><creatorcontrib>Yun, Chul-Ho</creatorcontrib><creatorcontrib>Chen, Yu-Hsuan</creatorcontrib><creatorcontrib>Huang, Chiung-Chiao</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career &amp; Technical Education Database</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Engineering Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Yàowu shi͡p︡in fenxi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ueng, Yune-Fang</au><au>Chen, Chien-Chih</au><au>Huang, Yu-Ling</au><au>Lee, I-Jung</au><au>Yun, Chul-Ho</au><au>Chen, Yu-Hsuan</au><au>Huang, Chiung-Chiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</atitle><jtitle>Yàowu shi͡p︡in fenxi</jtitle><addtitle>J Food Drug Anal</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>23</volume><issue>3</issue><spage>516</spage><epage>528</epage><pages>516-528</pages><issn>1021-9498</issn><eissn>2224-6614</eissn><abstract>Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.</abstract><cop>China (Republic : 1949- )</cop><pub>Elsevier B.V</pub><pmid>28911711</pmid><doi>10.1016/j.jfda.2015.03.005</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-6046-8356</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1021-9498
ispartof Yàowu shi͡p︡in fenxi, 2015-09, Vol.23 (3), p.516-528
issn 1021-9498
2224-6614
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9351787
source ScienceDirect Journals; PubMed Central
subjects Chromatography
CYP1A protein
Cytochrome
Cytochrome P450
Drug dosages
Enzymes
Females
Furanocoumarins
Ingredients
Males
Metabolism
Mice
Motility
NAD(P)H:quinone oxidoreductase
Nicotinamide
Nicotinamide adenine dinucleotide
Oral administration
Original
Phosphates
Physiology
Polyclonal antibodies
Proteins
Quinone oxidoreductase
Rodents
Ruta graveolens
Rutin
Sperm
Therapeutic applications
UDP-glucuronosyltransferase
Uridine
title Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20aqueous%20extract%20of%20Ruta%20graveolens%20and%20its%20ingredients%20on%20cytochrome%20P450,%20uridine%20diphosphate%20(UDP)-glucuronosyltransferase,%20and%20reduced%20nicotinamide%20adenine%20dinucleotide%20(phosphate)%20(NAD(P)H)-quinone%20oxidoreductase%20in%20mice&rft.jtitle=Ya%CC%80owu%20shi%CD%A1p%EF%B8%A1in%20fenxi&rft.au=Ueng,%20Yune-Fang&rft.date=2015-09-01&rft.volume=23&rft.issue=3&rft.spage=516&rft.epage=528&rft.pages=516-528&rft.issn=1021-9498&rft.eissn=2224-6614&rft_id=info:doi/10.1016/j.jfda.2015.03.005&rft_dat=%3Cproquest_pubme%3E2049904915%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2049904915&rft_id=info:pmid/28911711&rfr_iscdi=true